BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 31097014)

  • 1. Epigenetics in cancer therapy and nanomedicine.
    Roberti A; Valdes AF; Torrecillas R; Fraga MF; Fernandez AF
    Clin Epigenetics; 2019 May; 11(1):81. PubMed ID: 31097014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenome-based personalized medicine in human cancer.
    Yan W; Herman JG; Guo M
    Epigenomics; 2016 Jan; 8(1):119-33. PubMed ID: 26344672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of epigenetics in malignant pleural mesothelioma.
    Vandermeers F; Neelature Sriramareddy S; Costa C; Hubaux R; Cosse JP; Willems L
    Lung Cancer; 2013 Sep; 81(3):311-318. PubMed ID: 23790315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the potential of epigenetic therapy to target solid tumors.
    Ahuja N; Easwaran H; Baylin SB
    J Clin Invest; 2014 Jan; 124(1):56-63. PubMed ID: 24382390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of epigenetic therapy in solid tumours--lessons from the past.
    Azad N; Zahnow CA; Rudin CM; Baylin SB
    Nat Rev Clin Oncol; 2013 May; 10(5):256-66. PubMed ID: 23546521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic therapy for solid tumors: from bench science to clinical trials.
    Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N
    Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Deacetylase Inhibitors in Cancer Therapy.
    Sun Y; Sun Y; Yue S; Wang Y; Lu F
    Curr Top Med Chem; 2018; 18(28):2420-2428. PubMed ID: 30526462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy.
    Chen F; Shi Y; Zhang J; Liu Q
    Curr Drug Targets; 2020; 21(11):1084-1098. PubMed ID: 32410563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising strategies: Combination of epigenetic inhibitors for cancer therapy.
    Gronemeyer H
    Int J Cancer; 2020 Nov; 147(10):2656-2657. PubMed ID: 32599650
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases.
    Fandy TE
    Curr Med Chem; 2009; 16(17):2075-85. PubMed ID: 19519382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological targeting of the cancer epigenome.
    Mabe NW; Perry JA; Malone CF; Stegmaier K
    Nat Cancer; 2024 Jun; 5(6):844-865. PubMed ID: 38937652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics and oncology.
    Mummaneni P; Shord SS
    Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in nanomedicine-based delivery of histone deacetylase inhibitors for cancer therapy.
    Hafez DA; Hassanin IA; Teleb M; Khattab SN; Elkhodairy KA; Elzoghby AO
    Nanomedicine (Lond); 2021 Oct; 16(25):2305-2325. PubMed ID: 34551585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics in radiotherapy: where are we heading?
    Smits KM; Melotte V; Niessen HE; Dubois L; Oberije C; Troost EG; Starmans MH; Boutros PC; Vooijs M; van Engeland M; Lambin P
    Radiother Oncol; 2014 May; 111(2):168-77. PubMed ID: 24861629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma epigenetics: novel mechanisms, markers, and medicines.
    Lee JJ; Murphy GF; Lian CG
    Lab Invest; 2014 Aug; 94(8):822-38. PubMed ID: 24978641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer.
    Mohammad HP; Barbash O; Creasy CL
    Nat Med; 2019 Mar; 25(3):403-418. PubMed ID: 30842676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epi-drugs as triple-negative breast cancer treatment.
    Idrissou M; Sanchez A; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
    Epigenomics; 2020 Apr; 12(8):725-742. PubMed ID: 32396394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic drugs take on cancer.
    Kaiser J
    Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.